These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 16098003)
21. Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia. Fischler B; Tack J; De Gucht V; Shkedy ZI; Persoons P; Broekaert D; Molenberghs G; Janssens J Gastroenterology; 2003 Apr; 124(4):903-10. PubMed ID: 12671886 [TBL] [Abstract][Full Text] [Related]
22. Comparison of gastrointestinal symptoms and psychological factors of functional dyspepsia to peptic ulcer or panic disorder patients. Tominaga K; Higuchi K; Iketani T; Ochi M; Kadouchi K; Tanigawa T; Shiba M; Watanabe T; Fujiwara Y; Oshitani N; Nagata T; Kiriike N; Arakawa T Inflammopharmacology; 2007 Apr; 15(2):84-9. PubMed ID: 17450448 [TBL] [Abstract][Full Text] [Related]
23. Increased frequency of gastrointestinal symptoms in patients with fibromyalgia and associated factors: a comparative study. Pamuk ON; Umit H; Harmandar O J Rheumatol; 2009 Aug; 36(8):1720-4. PubMed ID: 19567625 [TBL] [Abstract][Full Text] [Related]
24. Functional dyspepsia: not all roads seem to lead to rome. van Kerkhoven LA; Laheij RJ; Meineche-Schmidt V; Veldhuyzen-van Zanten SJ; de Wit NJ; Jansen JB J Clin Gastroenterol; 2009 Feb; 43(2):118-22. PubMed ID: 18719513 [TBL] [Abstract][Full Text] [Related]
25. Aerophagia in adults: a comparison with functional dyspepsia. Chitkara DK; Bredenoord AJ; Rucker MJ; Talley NJ Aliment Pharmacol Ther; 2005 Nov; 22(9):855-8. PubMed ID: 16225495 [TBL] [Abstract][Full Text] [Related]
26. Predictors of the placebo response in functional dyspepsia. Talley NJ; Locke GR; Lahr BD; Zinsmeister AR; Cohard-Radice M; D'Elia TV; Tack J; Earnest DL Aliment Pharmacol Ther; 2006 Apr; 23(7):923-36. PubMed ID: 16573795 [TBL] [Abstract][Full Text] [Related]
27. The validity of a symptom diary in ratings of dyspepsia measured against a detailed interview: do patients and clinicians agree in their assessment of symptoms? Madsen LG; Hansen JM; Grønvold M; Bytzer P Aliment Pharmacol Ther; 2007 Sep; 26(6):905-12. PubMed ID: 17767475 [TBL] [Abstract][Full Text] [Related]
28. Gastrointestinal symptoms in bulimia nervosa: effects of treatment. Chami TN; Andersen AE; Crowell MD; Schuster MM; Whitehead WE Am J Gastroenterol; 1995 Jan; 90(1):88-92. PubMed ID: 7801956 [TBL] [Abstract][Full Text] [Related]
29. Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials. Vakil N; Laine L; Talley NJ; Zakko SF; Tack J; Chey WD; Kralstein J; Earnest DL; Ligozio G; Cohard-Radice M Am J Gastroenterol; 2008 Aug; 103(8):1906-19. PubMed ID: 18616658 [TBL] [Abstract][Full Text] [Related]
30. The use of pictograms improves symptom evaluation by patients with functional dyspepsia. Tack J; Carbone F; Holvoet L; Vanheel H; Vanuytsel T; Vandenberghe A Aliment Pharmacol Ther; 2014 Sep; 40(5):523-30. PubMed ID: 25052080 [TBL] [Abstract][Full Text] [Related]
32. Effect of tegaserod on esophageal pain threshold, regurgitation, and symptom relief in patients with functional heartburn and mechanical sensitivity. Rodriguez-Stanley S; Zubaidi S; Proskin HM; Kralstein JR; Shetzline MA; Miner PB Clin Gastroenterol Hepatol; 2006 Apr; 4(4):442-50. PubMed ID: 16616348 [TBL] [Abstract][Full Text] [Related]
33. Cancer symptom clusters: a validation study. Chen ML; Lin CC J Pain Symptom Manage; 2007 Dec; 34(6):590-9. PubMed ID: 17629670 [TBL] [Abstract][Full Text] [Related]
34. Dietary influence on electro-gastrography and association of alterations in gastric myoelectrical activity with symptoms in patients with functional dyspepsia. Lee KJ; Kim JH; Cho SW J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):59-64. PubMed ID: 16706813 [TBL] [Abstract][Full Text] [Related]
35. Correlations among electrogastrogram, gastric dysmotility, and duodenal dysmotility in patients with functional dyspepsia. Sha W; Pasricha PJ; Chen JD J Clin Gastroenterol; 2009 Sep; 43(8):716-22. PubMed ID: 19247205 [TBL] [Abstract][Full Text] [Related]
36. [Assessment of the efficacy and safety of the phytopharmacon STW 5 versus metoclopramide in functional dyspepsia--a retrolective cohort study]. Raedsch R; Hanisch J; Bock P; Sibaev A; Vinson B; Gundermann KJ Z Gastroenterol; 2007 Oct; 45(10):1041-8. PubMed ID: 17924300 [TBL] [Abstract][Full Text] [Related]
37. A new questionnaire for the diagnosis of dyspepsia. Bisbal-Murrugarra O; León-Barúa R; Berendson-Seminario R; Biber-Poillevard M Acta Gastroenterol Latinoam; 2002 May; 32(1):25-8. PubMed ID: 12136688 [TBL] [Abstract][Full Text] [Related]
39. Do distinct dyspepsia subgroups exist in the community? A population-based study. Choung RS; Locke GR; Schleck CD; Zinsmeister AR; Talley NJ Am J Gastroenterol; 2007 Sep; 102(9):1983-9. PubMed ID: 17581264 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study. Kupcinskas L; Lafolie P; Lignell A; Kiudelis G; Jonaitis L; Adamonis K; Andersen LP; Wadström T Phytomedicine; 2008 Jun; 15(6-7):391-9. PubMed ID: 18467083 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]